To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
EMBL bucks venture trend with first close
Life sciences-focused venture firm EMBL Ventures has held a first close for its second fund on €40m, despite institutional investors’ recent apathy towards venture in general.
